Last 45 quarters of trend data · Healthcare · Medical - Instruments & Supplies
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 30.53 | 23.58 | 20.24 | 18.90 | — | 20.86 | 26.80 | 22.64 | 27.07 | 17.34 | 46.89 | — | 23.19 | 24.94 | 34.32 | 19.70 | 10.56 | 9.76 | 14.42 | 15.84 | 7.71 |
| — | +13.0% | -24.5% | -16.5% | — | +20.3% | -42.9% | — | +16.7% | -30.5% | +36.6% | — | +119.5% | +155.5% | +138.1% | +24.4% | +37.0% | +30.5% | +63.1% | -37.3% | -66.6% | |
| P/S Ratio | 4.14 | 4.02 | 3.61 | 3.58 | 3.44 | 4.12 | 4.86 | 4.34 | 4.55 | 4.24 | 4.54 | 5.08 | 4.91 | 4.34 | 4.27 | 4.48 | 3.36 | 3.31 | 3.61 | 3.65 | 3.11 |
| — | -2.6% | -25.7% | -17.5% | -24.3% | -2.7% | +7.2% | -14.5% | -7.3% | -2.4% | +6.1% | +13.4% | +46.2% | +31.0% | +18.3% | +22.8% | +7.9% | +9.0% | +11.2% | -14.1% | +7.0% | |
| P/B Ratio | 3.43 | 3.21 | 3.01 | 3.03 | 3.00 | 3.53 | 3.75 | 3.55 | 3.82 | 3.69 | 3.42 | 3.86 | 3.80 | 3.66 | 3.34 | 3.59 | 4.03 | 4.31 | 4.51 | 4.39 | 5.04 |
| — | -9.1% | -19.8% | -14.7% | -21.6% | -4.3% | +9.6% | -8.1% | +0.5% | +0.7% | +2.3% | +7.4% | -5.5% | -15.1% | -25.9% | -18.3% | -20.2% | -28.0% | -30.2% | -29.0% | +19.9% | |
| P/FCF | 18.44 | 19.55 | 11.68 | 11.09 | 26.79 | 29.60 | 14.27 | 11.80 | 17.51 | 23.58 | 20.79 | 16.87 | 28.93 | 20.79 | 29.74 | 14.71 | 4.78 | 9.25 | 11.28 | 6.88 | 9.45 |
| — | -34.0% | -18.2% | -6.1% | +53.0% | +25.6% | -31.4% | -30.0% | -39.5% | +13.4% | -30.1% | +14.6% | +505.0% | +124.7% | +163.7% | +114.0% | -49.4% | +14.4% | -1.1% | -63.0% | -63.0% | |
| EV / EBITDA | 17.39 | 16.31 | 12.51 | 11.89 | 54.00 | 14.49 | 16.19 | 13.97 | 14.91 | 15.53 | 20.83 | 60.74 | 14.47 | 13.68 | 17.05 | 12.34 | 7.17 | 7.06 | 9.42 | 10.52 | 5.91 |
| — | +12.6% | -22.7% | -14.9% | +262.1% | -6.7% | -22.3% | -77.0% | +3.1% | +13.6% | +22.2% | +392.3% | +101.6% | +93.7% | +81.0% | +17.2% | +21.3% | +28.6% | +37.4% | -27.6% | -48.9% | |
| EV / EBIT | 24.69 | 16.69 | 16.50 | 14.63 | 6227.48 | 15.84 | 19.45 | 16.21 | 19.39 | 20.49 | 24.95 | 126.05 | 16.66 | 17.83 | 25.19 | 16.99 | 8.41 | 8.17 | 12.11 | 13.47 | 6.58 |
| — | +5.4% | -15.2% | -9.8% | +32017.5% | -22.7% | -22.0% | -87.1% | +16.4% | +14.9% | -1.0% | +642.0% | +97.9% | +118.2% | +107.9% | +26.1% | +27.9% | +30.9% | +56.0% | -36.2% | -65.8% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 61.0% | 56.0% | 60.9% | 56.3% | 37.5% | 56.8% | 56.4% | 55.4% | 55.3% | 56.0% | 52.9% | 37.3% | 57.1% | 57.5% | 54.0% | 54.8% | 65.9% | 67.0% | 62.9% | 60.1% | 70.6% |
| — | -1.5% | +7.9% | +1.7% | -32.1% | +1.4% | +6.7% | +48.4% | -3.2% | -2.6% | -2.0% | -31.9% | -13.4% | -14.2% | -14.1% | -8.7% | -6.6% | -8.6% | -9.1% | +6.0% | +34.9% | |
| Operating Margin | 17.4% | 22.6% | 22.6% | 24.9% | -0.7% | 22.5% | 23.3% | 24.1% | 23.9% | 19.6% | 14.0% | 0.1% | 26.5% | 24.4% | 14.8% | 26.3% | 41.4% | 43.6% | 33.4% | 30.7% | 51.8% |
| — | +0.6% | -3.0% | +3.1% | -102.9% | +15.0% | +66.1% | +16865.5% | -9.8% | -19.9% | -5.2% | -99.5% | -35.9% | -44.0% | -55.7% | -14.3% | -20.1% | -20.7% | -28.9% | +32.2% | +150.5% | |
| Net Margin | 13.8% | 17.1% | 17.8% | 19.0% | -1.7% | 19.7% | 18.1% | 19.2% | 16.7% | 24.3% | 9.6% | -4.1% | 21.3% | 17.4% | 12.5% | 22.8% | 31.7% | 33.9% | 25.0% | 23.0% | 40.3% |
| — | -13.1% | -1.3% | -1.0% | -110.4% | -19.2% | +88.6% | +567.4% | -21.6% | +39.5% | -23.0% | -118.1% | -32.9% | -48.6% | -50.1% | -0.8% | -21.3% | -16.5% | -32.0% | +37.1% | +216.5% |
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 11.1% | 3.5% | 3.8% | 4.1% | -0.4% | 4.1% | 3.5% | 4.0% | 3.6% | 5.1% | 1.8% | -0.8% | 4.2% | 3.8% | 2.4% | 4.7% | 9.8% | 11.4% | 8.1% | 7.0% | 17.6% |
| — | -14.3% | +6.9% | +3.7% | -110.4% | -20.4% | +99.4% | +614.0% | -14.9% | +35.6% | -26.1% | -116.6% | -57.0% | -67.1% | -70.4% | -33.3% | -44.2% | -47.8% | -59.2% | +10.4% | +296.3% | |
| ROA | 6.2% | 2.0% | 2.1% | 2.2% | -0.2% | 2.2% | 2.0% | 2.2% | 2.0% | 2.8% | 1.0% | -0.4% | 2.3% | 2.0% | 1.3% | 2.4% | 4.8% | 5.5% | 3.8% | 3.2% | 8.0% |
| — | -12.4% | +6.2% | +1.7% | -110.2% | -19.7% | +101.8% | +612.5% | -15.2% | +37.2% | -23.9% | -117.8% | -51.9% | -62.8% | -65.7% | -25.0% | -39.0% | -38.2% | -46.9% | +59.4% | +442.1% | |
| ROIC | 9.4% | 3.1% | 3.1% | 3.4% | -0.1% | 3.1% | 3.2% | 3.6% | 3.5% | 2.8% | 1.9% | 0.0% | 3.7% | 3.6% | 1.9% | 3.6% | 7.6% | 7.8% | 5.3% | 4.5% | 10.9% |
| — | +1.7% | -2.8% | -5.3% | -102.7% | +9.1% | +69.6% | +18209.8% | -6.1% | -21.2% | -1.7% | -99.5% | -51.2% | -53.8% | -63.7% | -20.5% | -30.8% | -39.5% | -44.0% | +52.5% | +358.7% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.52 | 0.48 | 0.52 | 0.52 | 0.55 | 0.53 | 0.52 | 0.52 | 0.53 | 0.55 | 0.58 | 0.55 | 0.54 | 0.56 | 0.60 | 0.57 | 0.65 | 0.68 | 0.75 | 0.81 | 0.73 |
| — | -9.7% | +0.4% | +0.8% | +3.4% | -3.9% | -10.5% | -5.7% | -1.2% | -0.9% | -3.4% | -3.7% | -16.9% | -18.3% | -19.6% | -29.8% | -11.7% | -19.6% | -35.9% | -44.8% | -57.3% | |
| Debt / EBITDA | 2.59 | 9.57 | 8.30 | 7.77 | 36.58 | 8.36 | 8.73 | 8.09 | 8.10 | 9.00 | 13.96 | 34.38 | 8.06 | 8.18 | 11.80 | 7.62 | 4.42 | 4.13 | 5.64 | 6.83 | 3.11 |
| — | +14.5% | -4.9% | -4.0% | +351.4% | -7.0% | -37.5% | -76.5% | +0.5% | +10.0% | +18.3% | +351.3% | +82.4% | +98.1% | +109.2% | +11.5% | +42.1% | +45.1% | +30.4% | -41.4% | -78.3% | |
| Current Ratio | 3.75 | 4.04 | 3.75 | 3.55 | 3.24 | 3.49 | 3.69 | 3.99 | 3.97 | 3.89 | 3.47 | 4.42 | 4.41 | 4.21 | 4.12 | 3.91 | 2.97 | 2.74 | 2.39 | 1.65 | 2.57 |
| — | +15.9% | +1.8% | -10.9% | -18.3% | -10.3% | +6.4% | -9.8% | -10.0% | -7.6% | -15.8% | +13.2% | +48.3% | +53.4% | +72.5% | +136.5% | +15.8% | +11.5% | +33.2% | +12.1% | +96.4% | |
| Quick Ratio | 3.06 | 3.32 | 3.06 | 2.81 | 2.52 | 2.78 | 3.03 | 3.32 | 3.29 | 3.18 | 2.95 | 3.73 | 3.69 | 3.50 | 3.45 | 3.32 | 2.57 | 2.34 | 2.01 | 1.31 | 2.13 |
| — | +19.3% | +0.9% | -15.4% | -23.4% | -12.6% | +2.6% | -10.9% | -10.9% | -9.0% | -14.4% | +12.2% | +43.5% | +49.6% | +71.8% | +154.2% | +20.8% | +13.4% | +36.4% | +12.1% | +105.3% | |
| Interest Coverage | 16.95 | 9.32 | 25.00 | 9.13 | 0.02 | 9.11 | 7.95 | 8.55 | 7.55 | 8.36 | 6.18 | 1.44 | 11.27 | 9.51 | 6.95 | 11.94 | 26.42 | 25.20 | 19.09 | 16.63 | 37.64 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 45 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying HOLX stock.
Hologic, Inc.'s current P/E is 30.5x. The average P/E over the last 3 quarters is 20.9x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Hologic, Inc.'s current operating margin is 17.4%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Hologic, Inc.'s business trajectory between earnings reports.